4. November 2023

๐—›๐—•๐—ข๐—ซ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ถ๐—ฒ๐˜€ ๐˜๐—ผ ๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ถ๐˜ƒ๐—ฒ ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜๐—ถ๐—ด๐—ถ๐—ผ๐˜‚๐˜€ ๐—˜๐—œ๐—– ๐—”๐—ฐ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ ๐—ณ๐˜‚๐—ป๐—ฑ๐—ถ๐—ป๐—ด

HBOX Therapies was selected as one of the most promising start-ups in Europe, thanks to our innovative product and robust business plan. This means we will receive a grant of โ‚ฌ2.5M and a potential follow-on investment to further advance and commercialize our medical device MiRA. We are very proud and grateful for this achievement. We will continue working hard to make our vision a reality and to improve clinical outcomes.

About EIC Accelerator:
The EIC Accelerator is the cornerstone of the Horizon Europe funding programme (2021-2027) by the European Commission and the European Innovation Council (EIC). It is designed for small and medium-sized enterprises, mid-cap companies and individuals who need financial support to bring their novel ideas, technologies and products to the market.

About MiRA:
MiRA (Miniatuarized Respiratory Assist) is expected to become the first alternative to invasive mechanical ventilation for patients suffering from acute lung failure. MiRA aims to reduce complication rates and improve outcomes, offering a new treatment regime for millions of patients annually.

 

Link zum LinkedIn Post.

noch

Tage bis zum Einsendeschluss der

Businessplanphase